等待開盤 11-26 09:30:00 美东时间
+2.180
+2.46%
今日重点评级关注:Ascendiant Capital:维持Aclarion"买入"评级,目标价从22美元升至23美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从24美元升至26美元
11-21 15:50
DA Davidson analyst Peter Winter maintains Texas Capital Bancshares (NASDAQ:TCBI) with a Neutral and maintains $91 price target.
11-21 01:50
The Texas Capital Funds Trust has authorized the liquidation of the Texas Capital Texas Small Cap Equity Index ETF (TXSS) due to its size and growth trajectory. The last day of trading on NASDAQ will be December 8, 2025, with liquidation proceeds distributed on December 15, 2025. Shareholders should consult tax advisers regarding potential tax implications. The Fund will be formally closed after distributions.
11-19 21:30
M&M Custard LLC, one of the largest franchisees of Freddy’s Frozen Custard & Steakburgers, has filed for Chapter 11 bankruptcy, placing the future of several locations in doubt even as the restaurants...
11-17 01:53
Treasury Secretary Scott Bessent said Sunday that President Donald Trump’s plan to send $2,000 “dividend” payments funded by tariff revenue cannot move forward without action from Congress. “We will s...
11-17 01:03
U.S. anti-dumping duties that could soar past 100% are threatening to shut Italian pasta makers out of one of their most important export markets. In Gragnano, the southern Italian town whose humid se...
11-16 23:46
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
11-12 11:43
Barclays analyst Jared Shaw maintains Texas Capital Bancshares (NASDAQ:TCBI) with a Underweight and raises the price target from $85 to $90.
11-11 23:36
今日重点评级关注:Guggenheim:上调Neumora Therapeutics评级至"买入",目标价14美元;韦德布什:上调Fate Therapeutics评级至"跑赢大市",目标价从5美元升至7美元
10-28 10:08
今日重点评级关注:摩根士丹利:维持Viking Therapeutics"超配"评级,目标价从98美元升至102美元;摩根大通:维持IDEAYA Biosciences"超配"评级,目标价从74美元升至79美元
10-24 09:51